All Stories

  1. Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis
  2. Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
  3. Outcomes of COVID-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol
  4. Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation
  5. Effects of Early Physical Therapy and Follow-Up in Acute Severe Coronavirus Disease 2019 Pneumonia: A Retrospective Observational Study
  6. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
  7. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
  8. Long-Term Antibiotics in Bronchiectasis
  9. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit
  10. Lung Ultrasound Score to Predict Outcomes in COVID-19
  11. A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile
  12. Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
  13. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
  14. Impact of an Intermediate Respiratory Care Unit on Clinical Outcomes of COVID-19 Patients
  15. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
  16. Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
  17. Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers
  18. Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
  19. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
  20. Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
  21. Salivary immunity and lower respiratory tract infections in non-elite marathon runners
  22. How is latent tuberculosis infection screening carried out in biological therapies candidates?
  23. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis
  24. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study
  25. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
  26. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis
  27. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
  28. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function
  29. Diagnostic challenges of bronchiectasis
  30. Pseudomonas aeruginosaresistance patterns and clinical outcomes in hospitalized exacerbations of COPD
  31. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization
  32. Variabilidad del fenotipo inflamatorio del asma en el esputo inducido. Frecuencia y causas
  33. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis
  34. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease